Fundamental Valuation Report Vaxart(VXRT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.70 (USD) 05/21/2021 Weighted Valuation$6.34 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $6.34 (USD) Valuation Methods This …

Vaxart (VXRT:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Voyager Therapeutics(VYGR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.26 (USD) 05/21/2021 Weighted Valuation$6.09 (USD) Overall RatingUndervalued by 43.0% Valuation Models Discounted Cash Flow: $6.10 (USD) …

Voyager Therapeutics (VYGR:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Provention Bio(PRVB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.80 (USD) 05/12/2021 Weighted Valuation$12.62 (USD) Overall RatingUndervalued by 85.5% Valuation Models Comparables: $12.94 (USD) Adjusted Book …

Provention Bio (PRVB:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Kala Pharmaceuticals(KALA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.45 (USD) 05/04/2021 Weighted Valuation$6.67 (USD) Overall RatingFairly valued to slightly Undervalued by 3.4% Valuation Models Adjusted …

Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Jounce Therapeutics(JNCE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.43 (USD) 04/30/2021 Weighted Valuation$10.14 (USD) Overall RatingUndervalued by 7.5% Valuation Models Adjusted Book Value: $10.14 (USD) …

Jounce Therapeutics (JNCE:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Cyclerion Therapeutics(CYCN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.78 (USD) 04/22/2021 Weighted Valuation$2.55 (USD) Overall RatingOvervalued by 8.1% Valuation Models Adjusted Book Value: $2.68 (USD) …

Cyclerion Therapeutics (CYCN:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Cardiff Oncology(CRDF:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.80 (USD) 04/22/2021 Weighted Valuation$9.27 (USD) Overall RatingUndervalued by 5.3% Valuation Models Comparables: $10.32 (USD) Adjusted Book …

Cardiff Oncology (CRDF:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Caladrius Biosciences(CLBS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$1.56 (USD) 04/21/2021 Weighted Valuation$1.60 (USD) Overall RatingFairly valued to slightly Undervalued by 2.5% Valuation Models Comparables: $2.71 …

Caladrius Biosciences (CLBS:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Cidara Therapeutics(CDTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.03 (USD) 04/20/2021 Weighted Valuation$1.92 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $1.67 (USD) (in order …

Cidara Therapeutics (CDTX:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Cara Therapeutics(CARA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.34 (USD) 04/19/2021 Weighted Valuation$26.30 (USD) Overall RatingFairly valued to slightly Overvalued by 3.8% Valuation Models Adjusted …

Cara Therapeutics (CARA:NAS) Fundamental Valuation Report Read more »

Read More